Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Regimens in Suboptimal Liver Transplants
NCT00321074Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- May 2005
- Primary completion
- Oct 2007
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in Liver transplant rejection, sponsored by Astellas Pharma. Started May 2005; status: completed.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00321074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321074.